ISIN | CH0594527720 |
---|---|
Valor Number | 59452772 |
Bloomberg Global ID | UBPAIIX SW |
Fund Name | UBS (CH) Investment Fund - Equities Switzerland ESG Passive All II I-X-acc |
Fund Provider |
UBS Asset Management Switzerland AG, Zurich
8098 Zürich, Schweiz E-Mail: ubs-am-wholesale-switzerland@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Asset Management Switzerland AG, Zurich |
Representative in Switzerland | |
Distributor(s) |
UBS AG Basel Phone: +41 61 288 20 20 |
Asset Class | Bonds |
EFC Category | Equity Switzerland |
Distribution Policy | Accumulation |
Home Country | Switzerland |
Issuing Condition | The fund charges a transaction fee (contribution towards expenses incurred in the investment of new assets) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | Das Anlageziel dieses Teilvermögens besteht hauptsächlich darin, den repräsentativen Referenzindex SPI® ESG (TR) für den schweizerischen Aktienmarkt (Bench-mark) passiv nachzubilden und eine Performance zu erzielen, welche dessen Entwicklung entspricht. |
Peculiarities |
Current Price * | 1,231.74 CHF | 05.06.2025 |
---|---|---|
Previous Price * | 1,229.05 CHF | 04.06.2025 |
52 Week High * | 1,260.38 CHF | 03.03.2025 |
52 Week Low * | 1,060.82 CHF | 09.04.2025 |
NAV * | 1,231.74 CHF | 05.06.2025 |
Issue Price * | 1,231.74 CHF | 05.06.2025 |
Redemption Price * | 1,231.74 CHF | 05.06.2025 |
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 2,317,338,438 | |
Unit/Share Assets *** | 1,893,405,231 | |
Trading Information SIX |
YTD Performance | +9.70% |
31.12.2024 - 05.06.2025
31.12.2024 05.06.2025 |
---|---|---|
1 month | +1.81% |
05.05.2025 - 05.06.2025
05.05.2025 05.06.2025 |
3 months | -1.98% |
05.03.2025 - 05.06.2025
05.03.2025 05.06.2025 |
6 months | +8.10% |
05.12.2024 - 05.06.2025
05.12.2024 05.06.2025 |
1 year | +4.86% |
05.06.2024 - 05.06.2025
05.06.2024 05.06.2025 |
2 years | +12.55% |
05.06.2023 - 05.06.2025
05.06.2023 05.06.2025 |
3 years | +15.39% |
07.06.2022 - 05.06.2025
07.06.2022 05.06.2025 |
5 years | +27.77% |
11.02.2021 - 05.06.2025
11.02.2021 05.06.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 14.68% | |
---|---|---|
Roche Holding AG | 12.08% | |
Novartis AG Registered Shares | 11.80% | |
Zurich Insurance Group AG | 5.44% | |
UBS Group AG | 5.04% | |
Compagnie Financiere Richemont SA Class A | 4.99% | |
ABB Ltd | 4.40% | |
Holcim Ltd | 3.17% | |
Swiss Re AG | 2.77% | |
Lonza Group Ltd | 2.72% | |
Last data update | 30.04.2025 |
TER | 0.01% |
---|---|
TER date | 30.09.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | |
Ongoing Charges *** | 0.01% |
SRRI ***
|
|
SRRI date *** | 30.04.2025 |